In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...

Medically reviewed by Jay N. Yepuri, MD Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build ...

The guidelines support use of PPIs, dietary therapy, and biologics for EoE, and stress the importance of addressing both the ...

After battling with her own GI issues, Krystyna Houser took to innovating the Elemental Diet, a medical food which also ...

Study identifies eosinophil levels as key to predicting gastrointestinal lesions in eosinophilic granulomatosis, offering a ...

Medically reviewed by Qin Rao, MD Eosinophilic esophagitis (EoE) is a chronic (long-term) condition affecting the esophagus, ...

Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the ...

An elemental diet is a medical protocol that replaces food and drinks with liquid formula for people with serious GI ...

Esocap AG aims to transform the treatment of eosinophilic esophagitis with its drug delivery technology, ESO-101, designed to increase mucosal contact time and drug deposition in the esophagus. Data ...

REGN's Eylea faces a rapid decline in sales, impacting overall performance even though Dupixent maintains momentum. We advise investors to stay on the sidelines for now.

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...